We are a leader in the neuroendovascular field with over 3,700 global Associates across various disciplines, united by our slogan, “Game-changing impact.” Unlike other companies that focus on incremental improvements, we develop transformative innovations that advance physician practice and patient outcomes. Founded in 1997, we initially focused on medical devices for small blood vessels and later specialized in aneurysm therapy with neuroendovascular platinum coils. Since joining Terumo® Corporation in 2006, we have expanded to offer 32 products, including technologies for treating ischemic stroke, carotid artery disease, and neurovascular malformations.
